These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12772146)

  • 21. Adding sufentanil to levobupivacaine or ropivacaine intrathecal anaesthesia affects the minimum local anaesthetic dose required.
    Parpaglioni R; Baldassini B; Barbati G; Celleno D
    Acta Anaesthesiol Scand; 2009 Oct; 53(9):1214-20. PubMed ID: 19650807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of parturient height on the median effective dose of intrathecally administered ropivacaine.
    Yu X; Zhang F
    Ann Saudi Med; 2016; 36(5):328-333. PubMed ID: 27710984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose combined spinal-epidural anesthesia for cesarean delivery: a comparison of three plain local anesthetics.
    Coppejans HC; Vercauteren MP
    Acta Anaesthesiol Belg; 2006; 57(1):39-43. PubMed ID: 16617756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary effects of bupivacaine, ropivacaine, and levobupivacaine in parturients undergoing spinal anaesthesia for elective caesarean delivery: a randomised controlled study.
    Lirk P; Kleber N; Mitterschiffthaler G; Keller C; Benzer A; Putz G
    Int J Obstet Anesth; 2010 Jul; 19(3):287-92. PubMed ID: 20605441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Horner's syndrome following epidural anesthesia with ropivacaine for cesarean delivery.
    Zahn PK; Van Aken HK; Marcus AE
    Reg Anesth Pain Med; 2002; 27(4):445-6. PubMed ID: 12132073
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined use of hyperbaric and hypobaric ropivacaine significantly improves hemodynamic characteristics in spinal anesthesia for caesarean section: a prospective, double-blind, randomized, controlled study.
    Quan Z; Tian M; Chi P; Li X; He H; Luo C
    PLoS One; 2015; 10(5):e0125014. PubMed ID: 25970485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excretion of ropivacaine in breast milk during patient-controlled epidural analgesia after cesarean delivery.
    Matsota PK; Markantonis SL; Fousteri MZ; Pandazi AK; Manikis DE; Christodoulopoulou TC; Loizou MM; Kostopanagiotou GG
    Reg Anesth Pain Med; 2009; 34(2):126-9. PubMed ID: 19282712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spread of subarachnoid block, intraoperative local anaesthetic requirements and postoperative analgesic requirements in Caesarean section and total abdominal hysterectomy.
    Fassoulaki A; Gatzou V; Petropoulos G; Siafaka I
    Br J Anaesth; 2004 Nov; 93(5):678-82. PubMed ID: 15347609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous wound infiltration with ropivacaine for analgesia after caesarean section: a randomised, placebo-controlled trial.
    Reinikainen M; Syväoja S; Hara K
    Acta Anaesthesiol Scand; 2014 Sep; 58(8):973-9. PubMed ID: 25041495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ropivacaine abdominal wound infiltration and peritoneal spraying at cesarean delivery for preemptive analgesia.
    Bamigboye AA; Justus HG
    Int J Gynaecol Obstet; 2008 Aug; 102(2):160-4. PubMed ID: 18538773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimum effective local anesthetic dose of intrathecal hyperbaric ropivacaine and bupivacaine for cesarean section.
    Geng ZY; Wang DX; Wu XM
    Chin Med J (Engl); 2011 Feb; 124(4):509-13. PubMed ID: 21362272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the ropivacaine-reducing effect of low-dose sufentanil in intrathecal labor analgesia.
    Ortner CM; Posch M; Roessler B; Faybik P; Rützler K; Grabovica J; Kimberger O; Gustorff B
    Acta Anaesthesiol Scand; 2010 Sep; 54(8):1000-6. PubMed ID: 20546210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring the relative potencies of bupivacaine and ropivacaine in spinal anesthesia.
    Wildsmith JA; Selander DE
    Reg Anesth Pain Med; 2009; 34(1):73-4; author reply 734-5. PubMed ID: 19258992
    [No Abstract]   [Full Text] [Related]  

  • 34. Ropivacaine and bupivacaine: concentrating on dosing!
    Polley LS; Columb MO
    Anesth Analg; 2003 May; 96(5):1251-1253. PubMed ID: 12707115
    [No Abstract]   [Full Text] [Related]  

  • 35. The Dose-response of Intrathecal Ropivacaine Co-administered with Sufentanil for Cesarean Delivery under Combined Spinal-epidural Anesthesia in Patients with Scarred Uterus.
    Xiao F; Xu WP; Zhang YF; Liu L; Liu X; Wang LZ
    Chin Med J (Engl); 2015 Oct; 128(19):2577-82. PubMed ID: 26415793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ropivacaine: drug of choice? Or not?
    Camann W
    Anesthesiology; 2000 Jan; 92(1):286-7. PubMed ID: 10638935
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of epidural anaesthesia with ropivacaine 0.5% and bupivacaine 0.5% for caesarean section.
    Crosby E; Sandler A; Finucane B; Writer D; Reid D; McKenna J; Friedlander M; Miller A; O'Callaghan-Enright S; Muir H; Shukla R
    Can J Anaesth; 1998 Nov; 45(11):1066-71. PubMed ID: 10021954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ropivacaine serum concentration following peritoneal spraying and wound infiltration for pain after cesarean delivery.
    Bamigboye AA
    Int J Gynaecol Obstet; 2009 Apr; 105(1):68-9. PubMed ID: 19062011
    [No Abstract]   [Full Text] [Related]  

  • 39. Spinal anesthesia with a low dosage of local anesthetic for urgent cesarean delivery in a parturient with Klippel-Feil syndrome.
    Santonastaso DP; de Chiara A; Addis A; Pini R; Agnoletti V
    J Clin Anesth; 2019 Feb; 52():78-79. PubMed ID: 30218886
    [No Abstract]   [Full Text] [Related]  

  • 40. Cesarean section under epidural ropivacaine 0.75% in a parturient with severe pulmonary hypertension.
    Olofsson C; Bremme K; Forssell G; Ohqvist G
    Acta Anaesthesiol Scand; 2001 Feb; 45(2):258-60. PubMed ID: 11167175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.